Pharmacology of hearing and ototoxicity.
D000311:Adrenal Glands; D000617:Aminoglycosides / Q000009:adverse effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D002034:Bumetanide / Q000009:adverse effects; D003051:Cochlea / Q000032:analysis / Q000502:physiology; D004785:Environmental Pollutants / Q000009:adverse effects; D004917:Erythromycin / Q000009:adverse effects; D004976:Ethacrynic Acid / Q000009:adverse effects; D005260:Female; D005665:Furosemide / Q000009:adverse effects; D006168:Guinea Pigs; D006309:Hearing / Q000187:drug effects*; D006311:Hearing Disorders / Q000139:chemically induced*; D006801:Humans; D007668:Kidney / Q000502:physiology; D010053:Ovary / Q000502:physiology; D011802:Quinidine / Q000009:adverse effects; D011803:Quinine / Q000009:adverse effects; D012640:Seizures / Q000503:physiopathology*; D013961:Thyroid Gland / Q000502:physiology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D004785:Environmental Pollutants; D002034:Bumetanide; D004917:Erythromycin; D005665:Furosemide; D011803:Quinine; D011802:Quinidine; D004976:Ethacrynic Acid